Home / Investor Relations / Intermolecular, Inc. Files Registration Statement for Proposed Initial Public Offering

Intermolecular, Inc. Files Registration Statement for Proposed Initial Public Offering

Press Releases

<<  Back
Intermolecular, Inc. Files Registration Statement for Proposed Initial Public Offering

July 29, 2011 – San Jose, Calif. -- Intermolecular, Inc., a semiconductor and clean energy technology platform company, announced today it has filed a registration statement on Form S-1 with the Securities and Exchange Commission (SEC) for a proposed initial public offering. Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC and Barclays Capital Inc. will act as joint book-running managers for the offering with Pacific Crest Securities LLC and Needham & Company, LLC as co-managers. The number of shares to be offered in the proposed offering and the offering price have not yet been determined. 

A copy of the prospectus relating to these securities may be obtained, when of available, from: Morgan Stanley & Co. LLC, Prospectus Department, 180 Varick Street, 2nd Floor, New York, New York 10014, by phone at 1-866-718-1649, or by email at prospectus@morganstanley.com, J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, or by phone at 1-866-803-9204 or Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717, by phone at 1-888-603-5847 or by email at Barclaysprospectus@broadridge.com.

A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

About Intermolecular
Intermolecular’s approach to research and development consists of its proprietary high productivity combinatorial (HPC) platform, coupled with its multi-disciplinary team. Through paid collaborative development programs with customers, Intermolecular develops proprietary technology and intellectual property for customers focused on advanced materials, processes, integration and device architectures. Founded in 2004, Intermolecular is based in San Jose, California. 

Contact:
Jennifer Anselmo
Loomis Group
415.882.9494
anselmoj@loomisgroup.com